Artrya clears key US milestone for coronary device, targets FDA filing by year-end

Artrya (ASX:AYA) has taken an essential step toward US clearance of its Salix Coronary Flow module, confirming a successful Q-Submission meeting with the Food and Drug Administration that provided clear guidance for a 510(k) application. …